FIELD: pharmaceuticals.
SUBSTANCE: group of inventions can be used to prevent or treat inflammatory diseases. A pharmaceutical composition with anti-inflammatory action containing ribofuranosylhypoxanthine or its pharmaceutically acceptable salt, glutathione disulfide or its pharmaceutically acceptable salt, presented in the form of a coordination compound containing a Pt-S-glutathione bond, with a Pt content of -1.5×10-3 mol per 1 kg glutathione disulfide; and glutathione disulfide S-oxide is proposed. Also a medicinal product and its use for the prevention and treatment of inflammatory diseases of the lungs of an infectious or non-infectious genesis are proposed.
EFFECT: composition provides increased anti-inflammatory action, as well as the possibility of treating various inflammatory diseases without the side effects inherent in glucocorticoids.
9 cl, 11 dwg, 6 tbl, 2 ex
Authors
Dates
2023-08-11—Published
2022-10-05—Filed